COVID-19 and corticosteroids: a narrative review G El-Saber Batiha, AI Al-Gareeb, HM Saad, HM Al-Kuraishy Inflammopharmacology 30 (4), 1189-1205, 2022 | 67 | 2022 |
Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals HM Al-Kuraishy, GES Batiha, H Faidah, AI Al-Gareeb, HM Saad, ... Inflammopharmacology 30 (6), 2017-2026, 2022 | 63 | 2022 |
A potential link between visceral obesity and risk of Alzheimer’s disease HM Al-Kuraishy, AI Al-Gareeb, AA Alsayegh, ZH Hakami, NA Khamjan, ... Neurochemical research 48 (3), 745-766, 2023 | 52 | 2023 |
Statins use in Alzheimer disease: bane or boon from frantic search and narrative review N Alsubaie, HM Al-Kuraishy, AI Al-Gareeb, B Alharbi, M De Waard, ... Brain sciences 12 (10), 1290, 2022 | 51 | 2022 |
The potential role of growth differentiation factor 15 in COVID-19: a corollary subjective effect or not? AO Babalghith, HM Al-Kuraishy, AI Al-Gareeb, M De Waard, JM Sabatier, ... Diagnostics 12 (9), 2051, 2022 | 44 | 2022 |
Pentoxifylline and berberine mitigate diclofenac-induced acute nephrotoxicity in male rats via modulation of inflammation and oxidative stress M Alorabi, S Cavalu, HM Al-Kuraishy, AI Al-Gareeb, G Mostafa-Hedeab, ... Biomedicine & Pharmacotherapy 152, 113225, 2022 | 44 | 2022 |
A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19 G Mostafa-Hedeab, HM Al-Kuraishy, AI Al-Gareeb, P Jeandet, HM Saad, ... Inflammopharmacology 30 (3), 799-809, 2022 | 42 | 2022 |
The impact of Moringa oleifera on the health status of Nile tilapia exposed to aflatoxicosis EY Abdelhiee, ZI Elbialy, AH Saad, MAO Dawood, M Aboubakr, ... Aquaculture 533, 736110, 2021 | 38 | 2021 |
Long-term use of metformin and Alzheimer’s disease: beneficial or detrimental effects HM Al-Kuraishy, AI Al-Gareeb, HM Saad, GES Batiha Inflammopharmacology 31 (3), 1107-1115, 2023 | 37 | 2023 |
Benzodiazepines in Alzheimer’s disease: beneficial or detrimental effects HM Al-Kuraishy, AI Al-Gareeb, HM Saad, GES Batiha Inflammopharmacology 31 (1), 221-230, 2023 | 35 | 2023 |
Role of neuropilin 1 in COVID-19 patients with acute ischemic stroke AW Al-Thomali, HM Al-Kuraishy, AI Al-Gareeb, A K. Al-buhadiliy, ... Biomedicines 10 (8), 2032, 2022 | 35 | 2022 |
Montelukast and acute coronary syndrome: the endowed drug BM Alomair, HM Al-Kuraishy, AI Al-Gareeb, SM Al-Hamash, M De Waard, ... Pharmaceuticals 15 (9), 1147, 2022 | 34 | 2022 |
Metformin and growth differentiation factor 15 (GDF15) in type 2 diabetes mellitus: A hidden treasure HM Al‐kuraishy, AI Al‐Gareeb, A Alexiou, M Papadakis, EH Nadwa, ... Journal of diabetes 14 (12), 806-814, 2022 | 31 | 2022 |
NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective M Alrouji, HM Al‐kuraishy, AI Al‐Gareeb, A Alexiou, M Papadakis, ... Journal of Cellular and Molecular Medicine 27 (13), 1775-1789, 2023 | 30 | 2023 |
Pros and cons for statins use and risk of Parkinson's disease: An updated perspective HM Al‐kuraishy, AI Al‐Gareeb, A Alexiou, M Papadakis, AA Alsayegh, ... Pharmacology Research & Perspectives 11 (2), e01063, 2023 | 29 | 2023 |
Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal GES Batiha, HM Al-Kuraishy, AI Al-Gareeb, M Alruwaili, R AlRuwaili, ... Inflammopharmacology 31 (1), 1-7, 2023 | 29 | 2023 |
The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases M Alrouji, HM Al-Kuraishy, AI Al-Gareeb, A Alexiou, M Papadakis, ... Diabetology & Metabolic Syndrome 15 (1), 101, 2023 | 28 | 2023 |
The potential role of MUC16 (CA125) biomarker in lung cancer: a magic biomarker but with adversity HM Saad, GF Tourky, HM Al-Kuraishy, AI Al-Gareeb, AM Khattab, ... Diagnostics 12 (12), 2985, 2022 | 28 | 2022 |
Comparative study on growth and survival of larval and juvenile Dicentrarchus labrax rearing on rotifer and Artemia enriched with four different microalgae species MI Zaki, H Saad African Journal of Biotechnology 9 (24), 3676-3688, 2010 | 28 | 2010 |
Hypoxia-inducible factor 1 and preeclampsia: a new perspective SM Albogami, HM Al-Kuraishy, TJ Al-Maiahy, AK Al-Buhadily, ... Current Hypertension Reports 24 (12), 687-692, 2022 | 27 | 2022 |